Rhythm Pharmaceuticals, Inc. (RYTM)

Last Closing Price: 116.80 (2026-11-19)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Rhythm Pharmaceuticals, Inc. (RYTM) had Net Income of $-42.35M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$92.13M
Net Income
$-42.35M
$12.17M
$79.96M
$131.40M
$-39.27M
$-1.49M
$-40.76M
$-40.76M
$-41.37M
$-41.37M
$-41.37M
$-41.37M
$-39.27M
$-39.02M
69.05M
69.05M
$-0.61
$-0.61
Balance Sheet Financials
$419.36M
$0.57M
$23.77M
$443.13M
$150.89M
--
$90.70M
$241.59M
$87.97M
$184.87M
$201.54M
69.31M
Cash Flow Statement Financials
$-56.40M
$54.96M
$-12.81M
$54.82M
$41.26M
$-13.56M
$74.18M
--
$-1.46M
Fundamental Metrics & Ratios
2.78
--
--
--
--
86.79%
-42.63%
-42.63%
--
-44.24%
-45.97%
$-56.90M
--
--
--
0.21
0.39
2.35
38.22
-47.03%
-22.38%
-9.34%
-20.53%
$2.91
$-0.82
$-0.82